If resistance to Isoniazid (INH) and Rifampicin (RIF) is confirmed in the sample requested, rapid molecular testing for fluoroquinolone-resistant Mycobacterium tuberculosis (Sanger sequencing) will be performed. Additional sequencing results and MIC values for Quinolone-based antituberculosis drugs will be provided. This service is available for specimens identified as strains (solid or liquid) eligible for rapid molecular testing for fluoroquinolone-resistant Mycobacterium tuberculosis.
Method
Sequencing
Fluoroquinolone Resistance
Detection of gyrA or gyrB gene mutations
Turnaround Time
5 days after notification of rapid drug susceptibility results